🧬 Strategic Optionality: M&A Hygiene & Investor Fit | Mike Stadnisky Rerelease (Part 3/3)
May 4, 2026
In this episode of The Biotech Startups Podcast, Jon Chee sits down with Mike Stadnisky, Managing Director of Thielsen Capital, a seed-stage life science tools syndicate. A veteran of four-plus M&A cycles as CEO of FlowJo and Phytonix, Mike walks through the mechanics founders most often get wrong: when to call in partnership favors, how shared customers become acquisition seeds, what IP and cap table hygiene should look like before a deal, and why a rigorous financial model is your most powerful negotiating tool.
🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.
As a TBSP listener, you can get exclusive perks through Excedr's partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.
"A financial model is the strategy of a business expressed in numbers."
"A financial model is the strategy of a business expressed in numbers."
In this episode of The Biotech Startups Podcast, Jon Chee sits down with Mike Stadnisky, Managing Director of Thielsen Capital, a seed-stage life science tools syndicate. A veteran of four-plus M&A cycles as CEO of FlowJo and Phytonix, Mike walks through the mechanics founders most often get wrong: when to call in partnership favors, how shared customers become acquisition seeds, what IP and cap table hygiene should look like before a deal, and why a rigorous financial model is your most powerful negotiating tool.
Key Topics Covered:
- Patience in BD Partnerships: Why the right time to call in a favor is rarely when you're stressed — and how to use conference deadlines as quiet leverage.
- Shared Customers as M&A Seeds: How raving fans in a shared customer base are both your best BD signal and the earliest seed of an acquisition.
- Corporate and IP Hygiene: What to fix before anyone opens your data room — cap tables, NDA labeling, trade secrets, and VDR discipline.
- Financial Models for Acquirers: Why top-down TAM slides kill deals, how to hire a de facto CFO, and how to reveal scale breaks and pricing leverage.
- Thielsen Capital's Picks and Shovels Thesis: Why life science tools are the Gold Rush infrastructure play and why the power law VC model fails commercial biotech.
- Default Alive and Incentive Alignment: Charlie Munger's "show me the incentives" — and why the right cap table is a founder's most powerful lever.
If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.
Subscribe to the Podcast:
Find our guest, Mike Stadnisky at these links:
Website: https://www.thielsencapital.com/
Find our host, Jon Chee, at these links:
LinkedIn: https://www.linkedin.com/in/jonchee/
Learn more about Excedr:
LinkedIn: https://www.linkedin.com/company/excedr/
Website: https://www.excedr.com
Intro & Outro Songs Created by OkKyojin, Owned by Excedr:
Website: https://flow.page/kyojin
Resources & Articles:
What Is Financial Modeling & How Can It Help with Fundraising?: https://www.excedr.com/resources/what-is-financial-modeling
Exit Strategies in Life Sciences Venture Capital: https://www.excedr.com/blog/exit-strategies-in-life-sciences-venture-capital
Intellectual Property Strategy for Biotech Companies: https://www.excedr.com/resources/intellectual-property-strategy-for-biotechs
How Biotech Partnerships Support R&D: https://www.excedr.com/blog/how-biotech-partnerships-support-research
Why Some Biotech Startups Struggle to Scale: https://www.excedr.com/resources/why-some-biotech-startups-struggle-to-scale
Default Alive or Default Dead? (Paul Graham): https://paulgraham.com/aord.html
Companies, Universities, & People Mentioned:
FlowJo: https://www.flowjo.com
Phytonix: https://phytonix.com
Frank Slootman (CEO, Snowflake): https://www.linkedin.com/in/frankslootman
Carl June (Pioneer of CAR-T Therapy, University of Pennsylvania): https://en.wikipedia.org/wiki/Carl_H._June
Charlie Munger (Vice Chairman, Berkshire Hathaway): https://en.wikipedia.org/wiki/Charlie_Munger
Steven J. Visco (Co-founder & CEO, PolyPlus Battery Company): https://www.linkedin.com/in/steven-j-visco-2910b57
Timestamps:
00:00 Intro
01:36 Patience and Asymmetry in BD Partnerships
02:44 Using Conferences to Create Partnership Urgency
08:53 Shared Customers and the Seeds of M&A
12:41 Strategic Optionality and the FlowJo Acquisition Story
16:06 Corporate, IP, and Cap Table Hygiene for Exit Readiness
20:25 Building a Financial Model That Moves Acquirers
27:46 Thielsen Capital: The Life Science Tools Thesis
37:11 Power Law VC and the Overfunding Problem
42:09 Default Alive, Incentive Alignment, and Charlie Munger
54:42 Advice to Your 21-Year-Old Self
56:24 Outro
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.